AxoGen (AXGN) Tops Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts AXGN Hot Sheet
Join SI Premium – FREE
AxoGen (NASDAQ: AXGN) reported Q4 EPS of $0.07, $0.01 better than the analyst estimate of $0.06. Revenue for the quarter came in at $59.9 million versus the consensus estimate of $58.25 million.
For earnings history and earnings-related data on AxoGen (AXGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barclays Starts DKSH Holding AG (DKSH:SW) at Overweight
- JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight
- UBS Reiterates Neutral Rating on Brenntag AG (BNR:GR) (BNTGY)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
